ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock

NACompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2022

Study Completion Date

January 31, 2023

Conditions
Cardiogenic Shock
Interventions
DEVICE

Veno-arterial extracorporeal membrane oxygenation (ECMO)

Veno-arterial extracorporeal membrane oxygenation (ECMO) will be ineserted as soon as possible and set to achieve adequate organ and tissue perfusion.

OTHER

Early conservative therapy according to standard practice

Standard therapy including inotropes and vasopressors will be used to achieve hemodynamic stabilization and adequate tissue perfusion.

Trial Locations (4)

12808

General University Hospital, Prague

15030

Na Homolce Hospital, Prague

30460

University Hospital Pilsen, Pilsen

Unknown

Regional Hospital Liberec, Liberec

All Listed Sponsors
collaborator

General University Hospital, Prague

OTHER

collaborator

University Hospital Pilsen

OTHER

lead

Na Homolce Hospital

OTHER

NCT02301819 - ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock | Biotech Hunter | Biotech Hunter